Scientist I
Dana-Farber / Boston Children's Cancer and Blood Disorders Center
Hannah Comeau is a scientist in the lab of Katherine Janeway, MD at the Dana-Farber Cancer Institute in Boston, Massachusetts. She is the lead coordinator for Dr. Janeway’s multicenter iCat2/GAIN Consortium Study and studies precision medicine in pediatric solid tumors. Hannah received her B.A. in Chemistry and Chinese language at The College of the Holy Cross and M.S in Biomedical Engineering at Johns Hopkins University. She conducted research in protein biochemistry under Kenneth Mills, PhD at The College of the Holy Cross, computational cancer biology under Zemin Zhang, PhD at Peking University, and regenerative immunology/immunoengineering under Jennifer Elisseeff, PhD at Johns Hopkins.
